Does the subspecialty of an intensive care unit (ICU) has an impact on outcome in patients suffering from aneurysmal subarachnoid hemorrhage?


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 09 01 2018
accepted: 22 03 2018
revised: 08 03 2018
pubmed: 1 4 2018
medline: 13 4 2019
entrez: 1 4 2018
Statut: ppublish

Résumé

We retrospectively compared the outcome of aneurysmal subarachnoid hemorrhage (aSAH) patients treated in a neurosurgical ICU (nICU) between 1990 and 2005 with that of patients treated in a general ICU (gICU) between 2005 and 2013 with almost identical treatment strategies. Among other parameters, we registered the initial Hunt and Hess grade, Fisher score, the incidence of vasospasm, and outcome. A multivariate analysis (logistic regression model) was performed to adjust for different variables. In total, 755 patients were included in this study with 456 patients assigned to the nICU and 299 patients to the gICU. Multivariate logistic regression analysis revealed no significant difference between the patient outcome treated in a nICU versus gICU after adjusting for different variables. The outcome of patients after aSAH is not influenced by the type of ICU (gICU versus nICU). The data do not allow claiming that aSAH patients need to be treated in a specialized ICU for obtaining better results. Parameters which might differ from hospital to hospital, especially warranty of neurosurgical expertise on gICU, have the potential to influence the results.

Identifiants

pubmed: 29603031
doi: 10.1007/s10143-018-0973-x
pii: 10.1007/s10143-018-0973-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-153

Références

J Neurosurg. 2000 Feb;92(2):284-90
pubmed: 10659016
Lancet. 2002 Oct 26;360(9342):1267-74
pubmed: 12414200
Lancet. 2005 Sep 3-9;366(9488):809-17
pubmed: 16139655
Neurocrit Care. 2006;5(2):85-92
pubmed: 17099253
Neurocrit Care. 2008;9(1):8-12
pubmed: 18080806
Acta Neurochir (Wien). 1991;110(1-2):57-64
pubmed: 1882720
Stroke. 2009 Mar;40(3):994-1025
pubmed: 19164800
Am J Respir Crit Care Med. 2009 Apr 15;179(8):676-83
pubmed: 19201923
J Neurosurg. 2010 Mar;112(3):626-30
pubmed: 19731990
J Neurosurg. 2011 Apr;114(4):935-41
pubmed: 21166569
Neurocrit Care. 2011 Jun;14(3):329-33
pubmed: 21424177
Neurocrit Care. 2011 Jun;14(3):334-40
pubmed: 21424884
Neurosurgery. 2011 Aug;69(2):261-6; discussion 266-7
pubmed: 21499142
Neurocrit Care. 2011 Dec;15(3):477-80
pubmed: 21519958
Neurocrit Care. 2012 Feb;16(1):63-71
pubmed: 21847702
Lancet. 2012 Jul 7;380(9836):44-9
pubmed: 22633825
Curr Opin Crit Care. 2014 Apr;20(2):174-81
pubmed: 24553337
Lancet. 2015 Feb 21;385(9969):691-7
pubmed: 25465111
Am J Nurs. 1979 Sep;79(9):1551-3
pubmed: 258560
Crit Care Res Pract. 2017;2017:6394105
pubmed: 29119023
Lancet. 1975 Mar 1;1(7905):480-4
pubmed: 46957
J Neurosurg. 1968 Jan;28(1):14-20
pubmed: 5635959
J Neurosurg. 1984 Jan;60(1):37-41
pubmed: 6689726
Neurosurgery. 1980 Jan;6(1):1-9
pubmed: 7354892

Auteurs

Dorothee Mielke (D)

Department of Neurosurgery, Georg-August-University Göttingen, Göttingen, Germany. dorothee.mielke@med.uni-goettingen.de.
Neurochirurgische Klinik, Georg-August-Universität Göttingen, Robert-Koch-Strasse 40, D-37075, Göttingen, Germany. dorothee.mielke@med.uni-goettingen.de.

Vesna Malinova (V)

Department of Neurosurgery, Georg-August-University Göttingen, Göttingen, Germany.

Onnen Moerer (O)

Department of Anesthesiology, Georg-August-University Göttingen, Göttingen, Germany.

Patricia Suntheim (P)

Department of Neurosurgery, Georg-August-University Göttingen, Göttingen, Germany.

Martin Voit (M)

Department of Neurosurgery, Georg-August-University Göttingen, Göttingen, Germany.

Veit Rohde (V)

Department of Neurosurgery, Georg-August-University Göttingen, Göttingen, Germany.
Department of Neurosurgery, University Hospital RWTH Aachen, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH